RSV Protection

RSV protection has been proven to prevent severe lower respiratory tract disease and reduce hospitalisation rates. Based on decades of research, these immunisations are used to protect infants, as well as older adults from severe RSV.

As part of the National RSV Mother and Infant Protection Program, RSV protection for babies is now available across the country, either as RSV vaccination for pregnant mothers or an immunisation for infants.

• Maternal Vaccination (called Abrysvo) – a vaccine given from 28 weeks of pregnancy so a mother can develop and pass on protective antibodies to her baby, providing protection during the most critical months after birth.

  The vaccine is available free for all eligible pregnant mothers across Australia through the National Immunisation Program (NIP). 

• Infant Immunisation (called Beyfortus) – ready-made antibodies that offer same-day protection against severe RSV infection. One injection offers infants protection throughout the RSV season.

  State and territory governments provide free infant immunisation for babies whose mothers did not receive RSV vaccination during pregnancy.  An overview of eligibility for infant RSV immunisation is currently underway and will provided prior to the 2026 RSV season, which most commonly occurs during winter.

Vaccination for older Australians aged 60 years and over provides lasting protection against RSV-related lower respiratory tract disease. 

Two vaccines for older Australians are available in Australia at a cost (on private prescription). They are not subsidised by the Australian Government. Private health insurance coverage may reduce the cost. 

The Department of Health and Aged Care provides further advice on recommendations and eligibility for RSV immunisations. Further information is also available in the Immunisation Handbook.